130 related articles for article (PubMed ID: 8917430)
1. The unglycosylated extracellular domain of type-II receptor for transforming growth factor-beta. A novel assay for characterizing ligand affinity and specificity.
Goetschy JF; Letourneur O; Cerletti N; Horisberger MA
Eur J Biochem; 1996 Oct; 241(2):355-62. PubMed ID: 8917430
[TBL] [Abstract][Full Text] [Related]
2. Characterization of recombinant soluble human transforming growth factor-beta receptor type II (rhTGF-beta sRII).
Tsang ML; Zhou L; Zheng BL; Wenker J; Fransen G; Humphrey J; Smith JM; O'Connor-McCourt M; Lucas R; Weatherbee JA
Cytokine; 1995 Jul; 7(5):389-97. PubMed ID: 7578976
[TBL] [Abstract][Full Text] [Related]
3. Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agent.
Vilchis-Landeros MM; Montiel JL; Mendoza V; Mendoza-Hernández G; López-Casillas F
Biochem J; 2001 Apr; 355(Pt 1):215-22. PubMed ID: 11256966
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of a pentameric complex of dimeric transforming growth factor beta ligand and a type I, II, III receptor in baculoviral-infected insect cells.
Matsuzaki K; Kan M; McKeehan WL
In Vitro Cell Dev Biol Anim; 1996 Jun; 32(6):345-60. PubMed ID: 8842749
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding.
De Crescenzo G; Pham PL; Durocher Y; O'Connor-McCourt MD
J Mol Biol; 2003 May; 328(5):1173-83. PubMed ID: 12729750
[TBL] [Abstract][Full Text] [Related]
6. Expression of recombinant human soluble type II transforming growth factor-beta receptor in Pichia pastoris and Escherichia coli: two powerful systems to express a potent inhibitor of transforming growth factor-beta.
Glansbeek HL; van Beuningen HM; Vitters EL; van der Kraan PM; van den Berg WB
Protein Expr Purif; 1998 Mar; 12(2):201-7. PubMed ID: 9518461
[TBL] [Abstract][Full Text] [Related]
7. The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands.
Lin HY; Moustakas A; Knaus P; Wells RG; Henis YI; Lodish HF
J Biol Chem; 1995 Feb; 270(6):2747-54. PubMed ID: 7852346
[TBL] [Abstract][Full Text] [Related]
8. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule.
Qian SW; Burmester JK; Tsang ML; Weatherbee JA; Hinck AP; Ohlsen DJ; Sporn MB; Roberts AB
J Biol Chem; 1996 Nov; 271(48):30656-62. PubMed ID: 8940041
[TBL] [Abstract][Full Text] [Related]
9. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
[TBL] [Abstract][Full Text] [Related]
10. Ectodomain cleavage and shedding of the type III transforming growth factor-beta receptor in lung membranes effect of temperature, ligand binding and membrane solubilization.
Philip A; Hannah R; O'connor-McCourt M
Eur J Biochem; 1999 May; 261(3):618-28. PubMed ID: 10215877
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of a transforming growth factor-beta Type II receptor cDNA from Xenopus laevis.
Dhanasekaran SM; Vempati UD; Kondaiah P
Gene; 2001 Jan; 263(1-2):171-8. PubMed ID: 11223255
[TBL] [Abstract][Full Text] [Related]
12. Photoaffinity labeling of the human brain cholecystokinin receptor overexpressed in insect cells. Solubilization, deglycosylation and purification.
Gimpl G; Anders J; Thiele C; Fahrenholz F
Eur J Biochem; 1996 May; 237(3):768-77. PubMed ID: 8647124
[TBL] [Abstract][Full Text] [Related]
13. Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.
Franzén P; ten Dijke P; Ichijo H; Yamashita H; Schulz P; Heldin CH; Miyazono K
Cell; 1993 Nov; 75(4):681-92. PubMed ID: 8242743
[TBL] [Abstract][Full Text] [Related]
14. Ligand-induced dimerization of the extracellular domain of the TGF-beta receptor type II.
Letourneur O; Goetschy JF; Horisberger M; Grütter MG
Biochem Biophys Res Commun; 1996 Jul; 224(3):709-16. PubMed ID: 8713111
[TBL] [Abstract][Full Text] [Related]
15. Cloning of an isoform of mouse TGF-beta type II receptor gene.
Suzuki A; Shioda N; Maeda T; Tada M; Ueno N
FEBS Lett; 1994 Nov; 355(1):19-22. PubMed ID: 7957954
[TBL] [Abstract][Full Text] [Related]
16. Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor.
Mendoza V; Vilchis-Landeros MM; Mendoza-Hernández G; Huang T; Villarreal MM; Hinck AP; López-Casillas F; Montiel JL
Biochemistry; 2009 Dec; 48(49):11755-65. PubMed ID: 19842711
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the contribution of receptor subdomains to the cooperative binding and internalization of transforming growth factor-beta (TGF-beta) type I and type II receptors.
Zwaagstra JC; Collins C; Langlois MJ; O'Connor-McCourt MD
Exp Cell Res; 2008 Aug; 314(14):2553-68. PubMed ID: 18598696
[TBL] [Abstract][Full Text] [Related]
18. Mapping of the ligand binding domain of the transforming growth factor beta receptor type III by deletion mutagenesis.
Pepin MC; Beauchemin M; Plamondon J; O'Connor-McCourt MD
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):6997-7001. PubMed ID: 8041735
[TBL] [Abstract][Full Text] [Related]
19. A human transforming growth factor-beta type II receptor that contains an insertion in the extracellular domain.
Hirai R; Fijita T
Exp Cell Res; 1996 Feb; 223(1):135-41. PubMed ID: 8635485
[TBL] [Abstract][Full Text] [Related]
20. Characterization of gastrin-releasing peptide receptor expressed in Sf9 insect cells by baculovirus.
Kusui T; Hellmich MR; Wang LH; Evans RL; Benya RV; Battey JF; Jensen RT
Biochemistry; 1995 Jun; 34(25):8061-75. PubMed ID: 7794919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
